AI approach reveals possible fusion of rare diseases in COVID-19 origins

Despite extensive research, the origins of COVID-19 remain elusive. In a new study published in the KeAi journal Advances in Biomarker Sciences and Technology (ABST), an AI-driven approach was adopted to examine DNA methylation patterns at 865,859 CpG sites in blood samples from early COVID-19 patients.

Major Cannabis ETF Change

We wrote about the death of a cannabis ETF, Amplify U.S. Alternative Harvest ETF, in our weekly newsletter on January 9th. Amplify didn’t share exactly

Read More »